Dr. Larry Gold is a professor at the University of Colorado at Boulder. He has been determined to change healthcare for the better through teaching, research, and debate among scientists and citizens throughout the world.  While at the University, he served as the Chairman of the Molecular, Cellular and Developmental Biology Department from 1988 to 1992.  Between 1995 and 2013, Dr. Gold received the CU Distinguished Lectureship Award, the National Institutes of Health Merit Award, the Career Development Award, the Lifetime Achievement Award from the Colorado Biosciences Association, and the Chiron Prize for Biotechnology.  In addition, Dr. Gold is a fellow of the National Academy of Inventors and the National Academy of Sciences.  Dr. Gold established his lab at the University of Colorado in Boulder in 1971. Starting with basic research on bacteria and bacteriophage, the lab shifted its focus to human disease following the invention of the SELEX process in 1989.  The Gold Lab today focuses on the utilization of biological and information technology to improve healthcare.

Larry was the Founder and Chairman and CEO of SomaLogic for many years. Prior to SomaLogic, he founded and was the Chairman of NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases. Before forming NeXagen, he also co-founded and served as co-director of research at Synergen, Inc., a biotechnology company later acquired by Amgen, Inc. Larry is the Chairman of the Colorado Longitudinal Study (COLS), a charity trying to study Colorado citizens using modern healthcare measurement.  He also is involved with a new pain management company called Ten Zero – he promises that this will be his last effort in biotechnology. He offers an annual GoldLab Symposium each May, a unique thought-provoking conference that brings together a variety of speakers addressing the challenges, successes, and cutting-edge issues affecting health and healthcare.